Skip to content

Insider · CIK 0001826361

Elizabeth A. Garofalo

director

Files at ACAD (ACADIA PHARMACEUTICALS INC), XENE (Xenon Pharmaceuticals Inc.), ALEC (Alector, Inc.). First filing Mar 6, 2025, latest Mar 6, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $90k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ACAD: ACADIA PHARMACEUTICALS INC

ACADOct 9, 2026 · close 19.78

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
44Moderate
ACADsell 3
ACADIA PHARMACEUTICALS INC
$90k
4,919 shares
-22%+27% from low-11% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 11, 2025ALEC
Alector, Inc.
AGrant or award
Common Stock
+28,700$0.00$089,950Jun 12, 2025
Jun 11, 2025ALEC
Alector, Inc.
AGrant or award
Stock Option (right to buy)derivative
+9,450$0.00$09,450Jun 12, 2025
Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AGrant or award
Share Option (Right to Buy)derivative
+17,012$0.00$017,012Jun 6, 2025
Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AGrant or award
Restricted Share Unitsderivative
+2,645$0.00$02,645Jun 6, 2025
May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
MOption exercise
Common Stock
+9,387--26,982Jun 2, 2025
May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
MOption exercise
Restricted Stock Unitsderivative
-9,387$0.00$00Jun 2, 2025
May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
AGrant or award
Director Stock Options (Right to Buy)derivative
+13,793$0.00$013,793Jun 2, 2025
May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
AGrant or award
Restricted Stock Unitsderivative
+8,107$0.00$08,107Jun 2, 2025
Mar 5, 2025ACAD
ACADIA PHARMACEUTICALS INC
SOpen-market sale
Common Stock
-4,919$18.23$90k17,595Mar 6, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Elizabeth A. Garofalo: insider trades and track record | InsiderTell